Brind.

Analysts revised earnings estimates positively for Tango Therapeutics, strengthening the upside view.

1 report, 1 independent Updated Jul 30
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Analysts revised earnings estimates positively for Tango Therapeutics, strengthening the upside view.

Who's involved

What this event is mainly about

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped
  • ZacksWall Street Analysts Believe Tango Therapeutics (TNGX) Could Rally 61.46%: Here's is How to Trade Shares of Tango Therapeutics, Inc. (TNGX) have gained 18.7% over the past four weeks to close the las